iBOT Israel Botanicals develops products for the manufacture and marketing of food supplements and cosmetics. The company currently manufactures probiotics, minerals, and plants for the treatment of iron deficiency, bone health, fertility, and more and plans to integrate a variety of cannabis and hemp-based products.
iBOT has an existing SL lab and licensed manufacturing facility for white-label botanical formulations.
iBOT has a full certification by the Israeli Ministry of Health and ISO certification bodies accrediting iBOT to GMP, ISO 9001, and HACCP standards. Extractions, formulations, and packaging are done on site. The facility has a wet division for liquid products such as tinctures and syrups as well as a dry division for tablets, capsules, and powders. All raw materials are tested before use, and all products are externally tested before release.
The company is owned by Citrine Biotech and Cannabis Investment Funds and iCAN, an enterprise enabling solutions for the cannabis industry.